SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-117144
Filing Date
2019-04-24
Accepted
2019-04-24 16:18:02
Documents
4
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A d689181ddefa14a.htm DEFA14A 17323
2 GRAPHIC g689181img01.jpg GRAPHIC 107399
3 GRAPHIC g689181img02.jpg GRAPHIC 198931
4 GRAPHIC g689181img03.jpg GRAPHIC 41282
  Complete submission text file 0001193125-19-117144.txt   491347
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36279 | Film No.: 19764051
SIC: 2834 Pharmaceutical Preparations